Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
HOUSTON, May 16, 2024 /PRNewswire/ -- Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...
HOUSTON, May 16, 2024 /PRNewswire/ -- Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...
